Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival
- DOI
- 10.1080/07853890.2026.2693452
- Published
- 2026-08-07
- Container
- Annals of Medicine
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/07853890.2026.2693452,
title = {Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival},
author = {John Hanna and Hong Li and Ryan Brown and Zain Ali Burney and Kawther Abdallah and Diana Basali and Jason Valent and Christy Samaras and Faiz Anwer and Jack Khouri and Shahzad Raza and Willem Van Heeckeren and Mazen Hanna and J. Emanuel Finet and Louis Williams and Sandy Mazzoni},
year = {2026},
journal = {Annals of Medicine},
doi = {10.1080/07853890.2026.2693452},
url = {https://doi.org/10.1080/07853890.2026.2693452}
}RIS
TY - JOUR TI - Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival AU - John Hanna AU - Hong Li AU - Ryan Brown AU - Zain Ali Burney AU - Kawther Abdallah AU - Diana Basali AU - Jason Valent AU - Christy Samaras AU - Faiz Anwer AU - Jack Khouri AU - Shahzad Raza AU - Willem Van Heeckeren AU - Mazen Hanna AU - J. Emanuel Finet AU - Louis Williams AU - Sandy Mazzoni PY - 2026 JO - Annals of Medicine DO - 10.1080/07853890.2026.2693452 UR - https://doi.org/10.1080/07853890.2026.2693452 ER -
APA
Hanna, J., Li, H., Brown, R., Burney, Z. A., Abdallah, K., Basali, D., Valent, J., Samaras, C., Anwer, F., Khouri, J., Raza, S., Heeckeren, W. V., Hanna, M., Finet, J. E., Williams, L., & Mazzoni, S. (2026). Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival. Annals of Medicine. https://doi.org/10.1080/07853890.2026.2693452
Source records
- crossref · retrieved 2026-09-25T18:33:32.206Z